MedPath

UNIVERSITY OF NEW MEXICO

🇺🇸United States
Ownership
-
Established
1889-01-01
Employees
6.7K
Market Cap
-
Website
https://www.unm.edu/

Clinical Trials

304

Active:9
Completed:175

Trial Phases

6 Phases

Early Phase 1:11
Phase 1:17
Phase 2:18
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (245 trials with phase data)• Click on a phase to view related trials

Not Applicable
173 (70.6%)
Phase 4
19 (7.8%)
Phase 2
18 (7.3%)
Phase 1
17 (6.9%)
Early Phase 1
11 (4.5%)
Phase 3
7 (2.9%)

WEAVE NM: Heart Health and Nutrition for Life

Not Applicable
Recruiting
Conditions
Hypertension
First Posted Date
2025-07-20
Last Posted Date
2025-07-31
Lead Sponsor
University of New Mexico
Target Recruit Count
240
Registration Number
NCT07074145
Locations
🇺🇸

First Nations Community HealthSource, Albuquerque, New Mexico, United States

Wellness, Alcohol, Vitals, and Emotions

Not Applicable
Not yet recruiting
Conditions
Alcohol Use
First Posted Date
2025-05-21
Last Posted Date
2025-05-21
Lead Sponsor
University of New Mexico
Target Recruit Count
120
Registration Number
NCT06982443
Locations
🇺🇸

University of New Mexico, Albuquerque, New Mexico, United States

Cervical Ripening Balloons for Same-Day Cervical Prep

Not Applicable
Recruiting
Conditions
Dilation and Evacuation
First Posted Date
2025-05-09
Last Posted Date
2025-05-09
Lead Sponsor
University of New Mexico
Target Recruit Count
70
Registration Number
NCT06964373
Locations
🇺🇸

University of New Mexico, Albuquerque, New Mexico, United States

Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation

Phase 2
Recruiting
Conditions
Long COVID
Long COVID Syndrome
Long COVID-19 Syndrome
PASC
PASC Post Acute Sequelae of COVID 19
First Posted Date
2025-04-23
Last Posted Date
2025-07-15
Lead Sponsor
University of New Mexico
Target Recruit Count
60
Registration Number
NCT06940609
Locations
🇺🇸

University of New Mexico Health Science Center, Albuquerque, New Mexico, United States

Effect of Tirzepatide on Markers of MASLD in Patients With Obesity

Early Phase 1
Recruiting
Conditions
MASLD
Obesity
Interventions
First Posted Date
2025-04-18
Last Posted Date
2025-07-14
Lead Sponsor
University of New Mexico
Target Recruit Count
8
Registration Number
NCT06934642
Locations
🇺🇸

University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 61
  • Next

News

Fluorescent Drug Bevonescein Shows Promise for Nerve-Sparing Surgery in Phase 1-2 Trial

A first-of-its-kind fluorescent drug called bevonescein successfully highlighted nerve tissue during surgery in a Phase 1-2 trial involving 27 cancer patients undergoing head and neck procedures.

Promising Alzheimer's Vaccine Targeting Tau Protein Advances Toward Human Trials

University of New Mexico researchers have developed a vaccine that generates antibodies against pathological tau protein (pT181), showing efficacy in both mice and non-human primates with strong immune responses.

Hospital-Based Addiction Consultation Significantly Improves OUD Treatment Outcomes, Study Shows

A clinical trial found that hospital-based addiction consultation services more than doubled the rate of medication initiation for opioid use disorder during hospitalization (57.3% vs 26.7% with usual care).

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.